NRF2 activation by myrcene restores redox balance and metabolic homeostasis in a mouse model of type 2 diabetes
3 Biotech · 2026-06 · 16 (6)
DOI: 10.1007/s13205-026-04864-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift 3 Biotech, online erschienen am 25.05.2026. Verfasst von Ruchi Pandey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar India. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar India.
- Department of Pathology, Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, Bihar India.
- National Institute of Pharmaceutical Education and Research (NIPER), Hajipur Export Promotions Industrial Park (EPIP), Industrial Area, Vaishali, Hajipur, 844102 Bihar India.
ORCID-Profile: Nitesh Kumar
Zitieren
APA
Pandey, R., Ray, A. K., Bisht, P., Choudhary, S., Kumar, P., Kumari, A., & Kumar, N. (2026). NRF2 activation by myrcene restores redox balance and metabolic homeostasis in a mouse model of type 2 diabetes. 3 Biotech, 16(6). https://doi.org/10.1007/s13205-026-04864-2
Vancouver
Pandey R, Ray AK, Bisht P, Choudhary S, Kumar P, Kumari A, et al. NRF2 activation by myrcene restores redox balance and metabolic homeostasis in a mouse model of type 2 diabetes. 3 Biotech. 2026;16(6). doi:10.1007/s13205-026-04864-2
BibTeX
@article{Pandey2026,
author = {Pandey, Ruchi and Ray, Adarsh Kumar and Bisht, Priya and Choudhary, Shalini and Kumar, Prabhat and Kumari, Anita and Kumar, Nitesh},
title = {NRF2 activation by myrcene restores redox balance and metabolic homeostasis in a mouse model of type 2 diabetes},
journal = {3 Biotech},
year = {2026},
volume = {16},
number = {6},
doi = {10.1007/s13205-026-04864-2}
}
EUVIMED